References

  1. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology: JASN. 2007;18(3):904-912. PubMed | Google Scholar

  2. Bonventre JV. Pathophysiology of AKI: injury and normal and abnormal repair. Contributions to nephrology. 2010; 165:9-17. PubMed | Google Scholar

  3. Urbschat A, Obermuller N, Haferkamp A. Biomarkers of kidney injury. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2011;16 Suppl 1:S22-30. PubMed | Google Scholar

  4. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney international. 2002;62(1):237-244. PubMed | Google Scholar

  5. Ibrahim M, Boghdadya, Mostafa M, Naggara EL, Mahmoud M, Emaraa, Rania M, Shazlyb EL KSM. Kidney injury molecule-1 as an early marker for acute kidney injury in critically ill patients. Menoufia Medical Journal. 2013; 26:98-104. Google Scholar

  6. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney international. 2007;71(10):967-970. PubMed | Google Scholar

  7. Kin Tekce B, Tekce H, Aktas G, Sit M. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy. Clinical and investigative medicine Medecine clinique et experimentale. 2014;37(6):E377-383. PubMed | Google Scholar

  8. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney Injury molecule-1: a sensitive quantitative biomarker for early detection of kidney Tubular injury. American Journal of Physiology Renal Physiology. 2006 Feb;290(2):F517-529. PubMed | Google Scholar

  9. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet (London, England). 2001;357(9268):1601-1608. PubMed | Google Scholar

  10. Doi K, Yuen PS, Eisner C, Hu X, Leelahavanichkul A, Schnermann J, Star RA. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. Journal of the American Society of Nephrology . 2009;20(6):1217-1221. PubMed | Google Scholar

  11. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more - Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association. European Renal Association. 2009;24(11):3265-3268. PubMed | Google Scholar

  12. OgrizoviĆ SS. The Importance Of Kim-1 Determination In Tissue And Urine Of Patients With Different Kidney Diseases. Znacaj Odre?ivanja Kim-1 U Tkivu I Urinu Bolesnikasa Razli?itim .Bolestima Bubrega. 2010;29(4):304-309. PubMed | Google Scholar

  13. Verdecchia P, Reboldi GP. Hypertension and microalbuminuria: the new detrimental duo. Blood pressure. 2004;13(4):198-211. PubMed | Google Scholar

  14. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annual review of pharmacology and toxicology. 2008;48:463-493. PubMed | Google Scholar

  15. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2009;53(1):16-25. PubMed | Google Scholar

  16. Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC nephrology. 2013;14:139. PubMed | Google Scholar

  17. El-Ashmawy N, El-Zamarany E, Khedr N, Abd El-Fattah A, Eltoukhy S. Kidney injury molecule-1 (Kim-1): an early biomarker for nephropathy in type II diabetic patients. Int J Diabetes Dev Ctries. 2015;1-8. PubMed | Google Scholar

  18. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. The Journal of pathology. 2007;212(2):209-217. PubMed | Google Scholar

  19. Poudel B, Yadav BK, Nepal AK, Jha B, Raut KB. Prevalence and association of microalbuminuria in essential hypertensive patients. North American journal of medical sciences. 2012; 4(8):331-335. PubMed | Google Scholar

  20. Futrakul N, Sridama V, Futrakul P. Microalbuminuria: a biomarker of renal microvascular disease. Renal failure. 2009;31(2):140-143. PubMed | Google Scholar

  21. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of internal medicine. 2003;139(2):137-147. PubMed | Google Scholar

  22. Bishop ML, Fody EP, Schoeff LE. Clinical Chemistry, Techniques, Principles, Correlations, 6th edn. Philadelphia: Lippincott Williams and Wilkins; 2010. Google Scholar

  23. Campese VM, Bianchi S, Bigazzi R. Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney Int Suppl. 1999;56(Suppl 71):S10-13. PubMed | Google Scholar

  24. Zacharias JM, Young TK, Riediger ND, Roulette J, Bruce SG. Prevalence, risk factors and awareness of albuminuria on a Canadian First Nation: A community -based screening study. Biomed central public Health. 2012;12:290. PubMed | Google Scholar

  25. Lesaic V. Serum and urinary Biomarkers determination and their significance in diagnosis of kidney disease. J of med biochemistry. 2010; 29:288-297. Google Scholar

  26. Baghel M, Modala S, Kumar BJP, Parimaia P. Correlation of Creatinine Clearance and urine Microalbuminuria in type 2 Diabetes Mellitus. Inter J Basic and App Med Sci. 2014;2277(2103):182-186. PubMed | Google Scholar